Koers Manzo Pharmaceuticals, Inc. Other OTC
Aandelen
MNZO
US56510D1063
Farmaceutische producten
Omzet 2003 | 3 mln. 2,78 mln. | Omzet 2004 | 3,07 mln. 2,84 mln. | Marktkapitalisatie | 8,07K 7,47K |
---|---|---|---|---|---|
Nettowinst (verlies) 2003 | -3 mln. -2,78 mln. | Nettowinst (verlies) 2004 | -4 mln. -3,7 mln. | EV/omzet 2003 | - |
Nettoschuld 2003 | 7,3 6,76 | Nettoschuld 2004 | 6,51 6,03 | EV/omzet 2004 | - |
K/w-verhouding 2003 |
-0,73
x | K/w-verhouding 2004 |
-0,42
x | Werknemers | - |
Dividendrendement 2003 * |
-
| Dividendrendement 2004 |
-
| Vrij verhandelbaar | 0% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+18,88% | 81,33 mld. | |
+14,11% | 9,14 mld. | |
-14,14% | 4,89 mld. | |
+43,39% | 4,61 mld. | |
+18,90% | 4,36 mld. | |
+7,93% | 2,26 mld. | |
-28,40% | 2,15 mld. | |
+15,93% | 2,1 mld. | |
-43,17% | 1,78 mld. |